Annual Working Capital
$469.18 M
-$41.46 M-8.12%
December 31, 2024
Summary
- As of March 9, 2025, ITOS annual working capital is $469.18 million, with the most recent change of -$41.46 million (-8.12%) on December 31, 2024.
- During the last 3 years, ITOS annual working capital has fallen by -$101.41 million (-17.77%).
- ITOS annual working capital is now -19.98% below its all-time high of $586.30 million, reached on December 31, 2022.
Performance
ITOS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$469.18 M
-$38.88 M-7.65%
December 31, 2024
Summary
- As of March 9, 2025, ITOS quarterly working capital is $469.18 million, with the most recent change of -$38.88 million (-7.65%) on December 31, 2024.
- Over the past year, ITOS quarterly working capital has dropped by -$38.88 million (-7.65%).
- ITOS quarterly working capital is now -30.94% below its all-time high of $679.35 million, reached on June 30, 2022.
Performance
ITOS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ITOS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.1% | -7.7% |
| 3 y3 years | -17.8% | -17.8% |
| 5 y5 years | +3542.7% | +3542.7% |
ITOS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.0% | at low | -30.9% | +5.5% |
| 5 y | 5-year | -20.0% | +3542.7% | -30.9% | +3542.7% |
| alltime | all time | -20.0% | +3542.7% | -30.9% | +3542.7% |
ITeos Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $469.18 M(-8.1%) | $469.18 M(-7.7%) |
| Sep 2024 | - | $508.06 M(-14.2%) |
| Jun 2024 | - | $591.94 M(+33.1%) |
| Mar 2024 | - | $444.83 M(-12.9%) |
| Dec 2023 | $510.64 M(-12.9%) | $510.64 M(-13.6%) |
| Sep 2023 | - | $590.90 M(+1.1%) |
| Jun 2023 | - | $584.52 M(-0.8%) |
| Mar 2023 | - | $589.04 M(+0.5%) |
| Dec 2022 | $586.30 M | $586.30 M(-13.1%) |
| Sep 2022 | - | $674.72 M(-0.7%) |
| Jun 2022 | - | $679.35 M(+1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $666.41 M(+16.8%) |
| Dec 2021 | $570.59 M(+75.8%) | $570.59 M(+53.4%) |
| Sep 2021 | - | $371.91 M(+28.7%) |
| Jun 2021 | - | $289.00 M(-7.7%) |
| Mar 2021 | - | $313.09 M(-3.5%) |
| Dec 2020 | $324.55 M(+2419.8%) | $324.55 M(-3.2%) |
| Sep 2020 | - | $335.41 M(+152.4%) |
| Jun 2020 | - | $132.88 M(-4.6%) |
| Mar 2020 | - | $139.30 M(+981.5%) |
| Dec 2019 | $12.88 M(-31.0%) | $12.88 M |
| Dec 2018 | $18.66 M | - |
FAQ
- What is iTeos Therapeutics annual working capital?
- What is the all time high annual working capital for iTeos Therapeutics?
- What is iTeos Therapeutics annual working capital year-on-year change?
- What is iTeos Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly working capital year-on-year change?
What is iTeos Therapeutics annual working capital?
The current annual working capital of ITOS is $469.18 M
What is the all time high annual working capital for iTeos Therapeutics?
iTeos Therapeutics all-time high annual working capital is $586.30 M
What is iTeos Therapeutics annual working capital year-on-year change?
Over the past year, ITOS annual working capital has changed by -$41.46 M (-8.12%)
What is iTeos Therapeutics quarterly working capital?
The current quarterly working capital of ITOS is $469.18 M
What is the all time high quarterly working capital for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly working capital is $679.35 M
What is iTeos Therapeutics quarterly working capital year-on-year change?
Over the past year, ITOS quarterly working capital has changed by -$38.88 M (-7.65%)